Venture Certified
| 기술평가보증기업(기금) | 2015-03-03 ~ 2017-03-02 | 20150101410 | 2015-03-03 |
| 기술평가보증기업(기금) | 2017-03-03 ~ 2019-03-02 | 20170101762 | 2015-03-03 |
| 벤처투자유형 | 2019-03-03 ~ 2021-03-02 | 20190300274 | 2015-03-03 |
| 벤처투자유형 | 2021-03-03 ~ 2024-03-02 | 20210304010012 | 2015-03-03 |
| 벤처투자유형 | 2024-03-03 ~ 2027-03-02 | 20240131010022 | 2015-03-03 |
Revenue CAGR -28.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 27.7B | 36.8B | 54.0B |
| Operating Profit | -80.3B | -105.6B | -111.2B |
| Net Profit | -69.8B | -94.8B | -100.5B |
| Total Assets | 221.3B | 320.1B | 411.0B |
| Total Liabilities | 92.4B | 127.7B | 132.1B |
| Total Equity | 128.9B | 192.4B | 278.9B |
Operating Loss: Op. profit -80B
3 Consecutive Years of Net Loss
▼ 39.1%
▲ 25.9%
▼ 17.9%
▲ 26.0%
▼ 27.0%
| Name | Position | Role |
|---|---|---|
| 김재선 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 수원시",
"ceo_name": "김재선",
"certificate": [
{
"cert_number": "20150101410",
"changes": "",
"disclosure_date": "2015-03-03",
"first_cert_date": "2015-03-03",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2015-03-03 ~ 2017-03-02"
},
{
"cert_number": "20170101762",
"changes": "",
"disclosure_date": "2017-03-07",
"first_cert_date": "2015-03-03",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2017-03-03 ~ 2019-03-02"
},
{
"cert_number": "20190300274",
"changes": "",
"disclosure_date": "2019-04-11",
"first_cert_date": "2015-03-03",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2019-03-03 ~ 2021-03-02"
},
{
"cert_number": "20210304010012",
"changes": "",
"disclosure_date": "2021-03-04",
"first_cert_date": "2015-03-03",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2021-03-03 ~ 2024-03-02"
},
{
"cert_number": "20240131010022",
"changes": "",
"disclosure_date": "2024-01-31",
"first_cert_date": "2015-03-03",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2024-03-03 ~ 2027-03-02"
}
],
"company_name": "제이투에이치바이오텍㈜",
"corp_no": "134811-*******",
"financials": {
"2022": {
"capital_stock": 1812718000,
"cost_of_sales": 4560711000,
"current_assets": 24804727000,
"current_liabilities": 11248561000,
"gross_profit": 842672000,
"net_income": -10045759000,
"net_income_bs": -10045759000,
"non_current_assets": 16297560000,
"non_current_liabilities": 1964975000,
"non_operating_expenses": 334858000,
"non_operating_income": 1412796000,
"operating_profit": -11123697000,
"revenue": 5403383000,
"sga_expenses": 11966369000,
"total_assets": 41102287000,
"total_equity": 27888751000,
"total_liabilities": 13213536000
},
"2023": {
"capital_stock": 1994417000,
"cost_of_sales": 3396999000,
"current_assets": 17080715000,
"current_liabilities": 10655674000,
"gross_profit": 283267000,
"net_income": -9483721000,
"net_income_bs": -9483721000,
"non_current_assets": 14927382000,
"non_current_liabilities": 2111232000,
"non_operating_expenses": 479195000,
"non_operating_income": 1551681000,
"operating_profit": -10556207000,
"revenue": 3680266000,
"sga_expenses": 10839474000,
"total_assets": 32008097000,
"total_equity": 19241191000,
"total_liabilities": 12766906000
},
"2024": {
"capital_stock": 2244658000,
"cost_of_sales": 2612556000,
"current_assets": 9871637000,
"current_liabilities": 8082761000,
"gross_profit": 153310000,
"net_income": -6982117000,
"net_income_bs": -6982117000,
"non_current_assets": 12255881000,
"non_current_liabilities": 1155798000,
"non_operating_expenses": 465011000,
"non_operating_income": 1515276000,
"operating_profit": -8032382000,
"revenue": 2765866000,
"sga_expenses": 8185692000,
"total_assets": 22127518000,
"total_equity": 12888959000,
"total_liabilities": 9238559000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "5,000,029,650",
"changes": "5,000,029,650",
"date": "2021-07-09"
},
{
"amount": "2,500,045,900",
"changes": "2,500,045,900",
"date": "2021-07-09"
},
{
"amount": "2,499,983,750",
"changes": "2,499,983,750",
"date": "2021-07-09"
},
{
"amount": "2,000,049,150",
"changes": "2,000,049,150",
"date": "2021-07-09"
},
{
"amount": "2,000,049,150",
"changes": "2,000,049,150",
"date": "2021-07-09"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2018-05-30"
}
],
"main_products": "신약 물질 개발",
"phone": "031-5182-****",
"years": [
2024,
2023,
2022
]
}